ArticleRSC medicinal chemistry2026
Extending the architecture of bolaamphiphilic disinfectants: an investigation of octenidine and isooctenidine analogs.
Article in RSC medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SuperBola Cationic Biocides with an Extended Bolaamphiphilic Structure: How Much Is Too Much?ACS infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Quaternary ammonium compounds (QACs) have been used in commercial disinfectants since the mid-1900s due to their strong antimicrobial activity and relatively low toxicity to eukaryotic cells. However, antimicrobial resistance to common disinfectant compounds has compromised their effectiveness over the past decades. The growing threat of resistant microbial pathogens has resulted in a need for novel QACs bearing new architectures and/or mechanisms of action. In light of this, our group has synthesized and investigated ∼1000 cationic biocides over the past 15 years. We have most recently turned our focus to octenidine, a potent biscationic QAC that is often used in the medical field as an effective antiseptic and to disinfect medical instruments. Octenidine is a bolaamphiphile, bearing two cationic residues separated by an alkyl linker; this architecture seems to provide strong activity against resistant bacteria. Its structural analog, isooctenidine, has been suggested to also possess potent antimicrobial activity, but with increased water solubility. To pursue this promising observation within an exciting disinfectant architecture, 24 isooctenidine analogs were synthesized, varying the carbon linker length and the length of the terminal alkyl chains. These compounds, along with octenidine and three of its structural analogs, were tested for bacterial inhibition; additionally, multiple pairs of octenidine and isooctenidine isomers were tested for water solubility and surface tension reduction. Ten different bolaamphiphilic QAC structures were found to inhibit an 8-strain panel of bacteria at single digit micromolar levels, but no differentiation was observed between isomeric compounds in either bioactivity or solution behavior.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.